Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (2): 156-158.DOI: 10.3969/j.issn.1673-8640.2020.02.014
Previous Articles Next Articles
Received:
2019-02-18
Online:
2020-02-29
Published:
2020-03-22
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.02.014
UF-5000 | 人工镜检 | 合计 | |
---|---|---|---|
阳性 | 阴性 | ||
阳性 | 230 | 105 | 335 |
阴性 | 70 | 595 | 665 |
合计 | 300 | 700 | 1 000 |
UF-5000 | 人工镜检 | 合计 | |
---|---|---|---|
阳性 | 阴性 | ||
阳性 | 230 | 105 | 335 |
阴性 | 70 | 595 | 665 |
合计 | 300 | 700 | 1 000 |
UF-1000i | 人工镜检 | 合计 | |
---|---|---|---|
阳性 | 阴性 | ||
阳性 | 196 | 219 | 415 |
阴性 | 104 | 481 | 585 |
合计 | 300 | 700 | 1 000 |
UF-1000i | 人工镜检 | 合计 | |
---|---|---|---|
阳性 | 阴性 | ||
阳性 | 196 | 219 | 415 |
阴性 | 104 | 481 | 585 |
合计 | 300 | 700 | 1 000 |
仪器 | 仪器 假阳性 例数 | 人工镜检 | ||
---|---|---|---|---|
复查结果 | 例数 | 百分比/% | ||
UF-1000i | 219 | 白细胞 | 31 | 14.2 |
红细胞 | 145 | 66.2 | ||
管型 | 18 | 8.2 | ||
小圆上皮细胞 | 18 | 8.2 | ||
其他 | 7 | 3.2 | ||
UF-5000 | 105 | 白细胞 | 17 | 16.2 |
红细胞 | 58 | 55.2* | ||
管型 | 11 | 10.5 | ||
小圆上皮细胞 | 11 | 10.5 | ||
其他 | 8 | 7.6 |
仪器 | 仪器 假阳性 例数 | 人工镜检 | ||
---|---|---|---|---|
复查结果 | 例数 | 百分比/% | ||
UF-1000i | 219 | 白细胞 | 31 | 14.2 |
红细胞 | 145 | 66.2 | ||
管型 | 18 | 8.2 | ||
小圆上皮细胞 | 18 | 8.2 | ||
其他 | 7 | 3.2 | ||
UF-5000 | 105 | 白细胞 | 17 | 16.2 |
红细胞 | 58 | 55.2* | ||
管型 | 11 | 10.5 | ||
小圆上皮细胞 | 11 | 10.5 | ||
其他 | 8 | 7.6 |
[1] | KANEKO K,KABEYA M,KONDO H,et al.Proteomic analysis of a urinary stone with two layers composed of calcium oxalate monohydrate and uric acid[J]. Nucleosides Nucleotides Nucleic Acids,2018,37(12):717-723. |
[2] | LI X,BAYLISS G,ZHUANG S.Cholesterol crystal embolism and chronic kidney disease[J]. Int J Mol Sci,2017,18(6):1120. |
[3] | CLAYSON D B,FISHBEIN L,COHEN S M.Effects of stones and other physical factors on the induction of rodent bladder cancer[J]. Food Chem Toxicol,1995,33(9):771-784. |
[4] | 胡晓波. 尿液检验质量的风险管理[J]. 检验医学,2017,32(11):947-948. |
[5] | 丛玉隆. 尿液沉渣检查标准化的建议[J]. 中华检验医学杂志,2002,25(4):249-250. |
[6] | COSTA-BAUZÁ A,PERELLÓ J,ISERN B,et al.Factors affecting calcium oxalate dehydrate fragmented calculi regrowth[J]. BMC Urol,2006,6:16. |
[7] | BAUMANN J M,AFFOLTER B,MEYER R.Crystal sedimentation and stone formation[J]. Urol Res,2010,38(1):21-27. |
[8] | 张培萍,刘丽华,董峻岭,等. 草酸钙的形成机理及影响因素[J]. 白求恩医科大学学报,2001,27(5):567-569. |
[9] | 余小祥,张瑞明,周大庆,等. 502例尿路结石患者资料分析[J]. 华南国防医学杂志,2012,26(6):599-601. |
[10] | 欧阳健明,郑辉. 泌尿系统尿酸结石研究中的化学基础[J]. 化学通报,2006,73(5):382-387. |
[11] | COLLIOU E,MARI A,DELAS A,et al.Oxalate nephropathy following vitamin C intake within intensive care unit[J]. Clin Nephrol,2017,88(12):354-358. |
[12] | COSSEY L N,RAHIM F,LARSEN C P.Oxalate nephropathy and intravenous vitamin C[J]. Am J Kidney Dis,2013,61(6):1032-1035. |
[13] | BHASIN B,ÜERKLI H M,ATTA M G.Primary and secondary hyperoxaluria:understanding the enigma[J]. World J Nephrol,2015,4(2):235-244. |
[14] | 刘常军,刘婷,董矜,等. UF-1000i尿沉渣分析仪假阳性结果分析[J]. 首都医科大学学报,2012,33(2):158-160. |
[15] | 丛玉隆,顾可梁,金大鸣,等. 关于常规尿液分析的几点共识[J]. 中华检验医学杂志,2012,35(9):790-791. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||